Archer Investment Corporation’s ProShares Ultra Health Care RXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-488
Closed -$19.8K 1206
2025
Q2
$19.8K Buy
488
+2
+0.4% +$82 ﹤0.01% 602
2025
Q1
$23.6K Hold
486
0.01% 562
2024
Q4
$21.4K Buy
486
+2
+0.4% +$100 0.01% 570
2024
Q3
$27K Buy
484
+2
+0.4% +$109 0.01% 529
2024
Q2
$24.5K Hold
482
0.01% 519
2024
Q1
$25.6K Hold
482
0.01% 501
2023
Q4
$22K Sell
482
-124
-20% -$5.19K 0.01% 514
2023
Q3
$25K Hold
606
0.01% 476
2023
Q2
$27K Buy
+606
New +$26.7K 0.01% 465

Other funds holding RXL

Archer Investment Corporation's RXL Position: Q3 2025 in Review

Archer Investment Corporation sold out of ProShares Ultra Health Care (RXL) in Q3 2025, closing a stake of 488 shares — an estimated $19.8K sold.

Archer Investment Corporation first reported a position in RXL in Q2 2023 and held it in 9 quarters. The position peaked at $27K in Q3 2024. 18 funds tracked by Wall St. Rank hold RXL as of Q3 2025.

  • Archer Investment Corporation reported no remaining ProShares Ultra Health Care position as of Q3 2025 after selling out during the quarter.
  • Archer Investment Corporation sold 488 ProShares Ultra Health Care shares in Q3 2025, an estimated $19.8K.
  • Archer Investment Corporation first reported a position in ProShares Ultra Health Care in Q2 2023 and held it in 9 quarters.
  • Archer Investment Corporation's ProShares Ultra Health Care position peaked at $27K in Q3 2024.
  • 18 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q3 2025.

Based on Archer Investment Corporation's 13F filing for Q3 2025, filed 3 Nov 2025.